Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31
Key details
Notice type
Sources Sought
NAICS code
621511
PSC / classification
Q301
Set-aside
—
Place of performance
Portland, OR
Response deadline
Jul 10, 2026, 05:00 PM
Solicitation summary
The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies. MRD is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL).
Read the full solicitation
Start free to unlock the complete notice, the contracting officer’s contact details, and every solicitation document.
Contracting officer
Activity in our index
7 opportunities · avg award $350k (1) · last active Jul 14, 2026.
Contact the contracting officer
Draft an outreach email with AI
A tailored, professional email to the contracting officer about this solicitation — written in seconds, grounded in this notice.
Free with an account · included with a WinAContract account. AI-written, grounded in this notice — review before sending.
Documents & attachments (1)
1 solicitation document on this notice
Start free to download the full solicitation package — statement of work, attachments and amendments.
Market intelligence
Send it to GovCon — docs + AI brief, automatically.
We pull the solicitation files and summarize what you need to know (1 document on this notice).